为您找到相关结果约317个

你是不是要搜索 期刊Gilteritinib 点击跳转

Study on the synthesis technology of anticancer drug Gilteritinib fumarate

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors

Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B

Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy

GILTERITINIB MEDIATED HYPOTHYROIDISM PRESENTING AS A LARGE PERICARDIAL EFFUSION

Mucocutaneous Sweet syndrome associated with the FLT3-inhibitor gilteritinib

Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells

Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells

Y Evolution of Gilteritinib Resistance from Residual Disease to Relapse

Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia

THE FLT3 INHIBITOR GILTERITINIB HAS ACTIVITY IN PATIENTS WITH AML

Interaction of the FLT3 Inhibitor Gilteritinib with Xenobiotic Uptake Transporters

Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19

为您找到相关结果约317个

共317条页码: 2/22页15条/页